INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 430m ago
HOUSE PTR30m ago
SEC 13F30m ago
ROBINHOOD CHAIN29m ago
Corporate insider
BS

Bizily Scott

Chief Legal OfficerCIK 0001920738

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score25
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
BS
Bizily ScottChief Legal Officer
FDMT4D Molecular Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$41K
9,810 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    4D Molecular Therapeutics, Inc.Chief Legal Officer · Jun 25, 2026
25
BS
Bizily ScottChief Legal Officer
FDMT4D Molecular Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL
$118K
9,810 sh
Jun 23, 2026
Jun 25, 2026
traded Jun 23, 2026
+2d
SEC FORM 4

Evidence

3
BS
Bizily ScottChief Legal Officer
FDMT4D Molecular Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
9,810 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence